ADC Therapeutics SA
ADCT
$1.89
$0.2011.83%
NYSE
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 194.70M | 250.87M | 274.27M | 300.12M | 234.29M |
Total Receivables | 31.76M | 20.32M | 24.03M | 22.87M | 23.19M |
Inventory | 17.45M | 18.39M | 16.07M | 15.19M | 16.00M |
Prepaid Expenses | 6.90M | 8.37M | 18.63M | 17.18M | 16.74M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 7.18M | 9.45M | -- | -- | -- |
Total Current Assets | 257.99M | 307.39M | 333.01M | 355.36M | 290.21M |
|
|||||
Total Current Assets | 257.99M | 307.39M | 333.01M | 355.36M | 290.21M |
Net Property, Plant & Equipment | 13.39M | 13.43M | 14.91M | 15.17M | 15.84M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1.16M | 1.16M | 1.17M | 992.00K | 986.00K |
Total Assets | 272.54M | 321.98M | 349.08M | 371.78M | 307.97M |
|
|||||
Total Accounts Payable | 15.59M | 18.03M | 14.37M | 10.71M | 14.32M |
Total Accrued Expenses | 31.42M | 49.82M | 40.07M | 34.57M | 35.54M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.37M | 1.37M | 8.70M | 1.42M | 1.43M |
Total Finance Division Other Current Liabilities | 9.41M | 11.25M | 4.54M | 10.94M | 11.70M |
Total Other Current Liabilities | 9.41M | 11.25M | 4.54M | 10.94M | 11.70M |
Total Current Liabilities | 57.79M | 80.47M | 67.68M | 57.63M | 62.99M |
|
|||||
Total Current Liabilities | 57.79M | 80.47M | 67.68M | 57.63M | 62.99M |
Long-Term Debt | 440.62M | 433.73M | 436.81M | 429.88M | 423.24M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 7.91M | 8.00M | 8.88M | 9.31M | 9.66M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 4.45M | 2.43M | 7.65M | 6.62M | 6.52M |
Total Liabilities | 510.76M | 524.62M | 521.03M | 503.45M | 502.42M |
|
|||||
Common Stock & APIC | 1.29B | 1.29B | 1.29B | 1.29B | 1.19B |
Retained Earnings | -1.53B | -1.49B | -1.46B | -1.42B | -1.38B |
Treasury Stock & Other | -1.30M | -1.64M | -19.00K | -577.00K | -703.00K |
Total Common Equity | -238.22M | -202.64M | -171.95M | -131.67M | -194.45M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -238.22M | -202.64M | -171.95M | -131.67M | -194.45M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -238.22M | -202.64M | -171.95M | -131.67M | -194.45M |
|